<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02699775</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A01671-48</org_study_id>
    <nct_id>NCT02699775</nct_id>
  </id_info>
  <brief_title>Effect of Repeated Botulinum Toxin Injection on Gait Pattern in Stroke Patients</brief_title>
  <acronym>TRITITOX</acronym>
  <official_title>Effect of 3 Consecutives Botulinum Toxin Injection on Gait Pattern in Stroke Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation Garches</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic stroke patients exhibit gait pattern alterations which are mainly due to spasticity
      and treated with repetitive multifocal botulinum toxin injection(BTI). Several studies
      demonstrated that single BTI-session in a single muscle of paretic lower limb(LL) improved
      kinematic gait parameters(GP) but surprisingly none of them assessed the effects of
      repetitive multifocal BTI on patient's gait pattern and their duration.

      The aim was to evaluate the impact of repetitive multifocal BTI-sessions on GP of chronic
      stroke patients. To that end, gait of patients will be compared using 3D-gait analysis after
      3 consecutives BTI sessions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All the patients will be treated with BTI . These injections will be performed under
      electrical stimulation control (~5mA). The dose, the number of site of injection per muscle
      is at the discretion of the physician according to patients' needs and physicians' routine
      clinical practice. The dilution the most commonly used will be 100 U for 2.5ml (XEOMIN®)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 12, 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>kinematics gait parameters</measure>
    <time_frame>3h</time_frame>
    <description>peak knee flexion in swing phase(°)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>spatiotemporal gait parameters</measure>
    <time_frame>3h</time_frame>
    <description>Gait velocity (m/s)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Botulinum Toxins Injection in Stroke Patients</condition>
  <arm_group>
    <arm_group_label>Chronic spastic stroke patients</arm_group_label>
    <description>Chronic spastic stroke patients treated regularly with botulinum toxin injection in lower limb muscles</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Motion Analysis</intervention_name>
    <description>Motion analysis is used to assess the modifications of gait pattern in chronic spastic stroke patients regularly treated with botulinum toxin injection</description>
    <arm_group_label>Chronic spastic stroke patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        STROKE PATIENTS
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 years

          -  a single hemispheric cerebral vascular lesion more than 6 months previously

          -  able to walk 10 meters without any assistance

          -  having benefited of at least 2 consecutive BTI sessions, second 3D gait analysis
             performed at least 3 months after the last BTI.

        Exclusion Criteria:

          -  patient's refusal to participate to the study

          -  Inability to read the selected text

          -  Inability to cooperate

          -  No affiliation to social security
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas ROCHE, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Raymond Poincare Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicolas ROCHE, MD PhD</last_name>
    <phone>0033147105409</phone>
    <email>roche.nicolas@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Raymond Poincaré hospital</name>
      <address>
        <city>Garches</city>
        <zip>92210</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas ROCHE, Md, PhD</last_name>
      <phone>0033147105409</phone>
      <email>roche.nicolas@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2016</study_first_submitted>
  <study_first_submitted_qc>March 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2016</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre d'Investigation Clinique et Technologique 805</investigator_affiliation>
    <investigator_full_name>Nicolas ROCHE</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>Botulinum toxin injections</keyword>
  <keyword>Stroke</keyword>
  <keyword>3D motion analysis</keyword>
  <keyword>Gait pattern</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

